Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
BRMS1 reduces the metastatic potential, but not the tumorogenicity, of human breast cancer and melanoma cell lines. De plus, nous expédions BRMS1 Anticorps (69) et BRMS1 Protéines (8) et beaucoup plus de produits pour cette protéine.
Showing 4 out of 4 products:
we identify a therapeutically exploitable posttranslational mechanism by which CK2alpha-mediated degradation of BRMS1 promotes metastases in lung cancer
our study characterized DAPK1 (Montrer DAPK1 Kits ELISA) as a novel transcriptional target of BRMS1. Transcriptional activation of DAPK1 (Montrer DAPK1 Kits ELISA) might be another important mechanism accounting for the metastasis suppressive activity of BRMS1.
BRMS1 promoter methylation and aberrant protein expression seem to be related to high-risk types of human papilloma virus-induced carcinogenesis in uterine cervix.
miR (Montrer MLXIP Kits ELISA)-346 promotes migration and invasion of nasopharyngeal carcinoma cells via targeting BRMS1.
expression of BRMS1 and/or HPA (Montrer HPSE Kits ELISA) might be closely related to the carcinogenesis, clinical biological behaviors, and prognosis of gallbladder adenocarcinoma
A novel link has been discussed between CDK2 (Montrer CDK2 Kits ELISA) expression and cell migration by characterizing the CDK2 (Montrer CDK2 Kits ELISA)-mediated phosphorylation of BRMS1.
Phosphorylation of BRMS1 by CDK2 (Montrer CDK2 Kits ELISA) regulates the migration of tumor cells.
Data show that Cullin3 exerts its function through promoting breast-cancer metastasis suppressor 1 (BRMS1) protein degradation, which was associated with epithelial-mesenchymal transition (EMT (Montrer ITK Kits ELISA)), migration and invasion.
The studies reviewed here with respect to BRMS1 structure, cellular effects, intracellular signaling, and clinical value consolidate the importance of BRMS1 in the development of metastasis.
Aberrant methylation of BRMS1 frequently occurs in the down-regulation of BRMS1 in triple negative breast cancer and that it may play a role in the metastasis of breast cancer.
findings indicate the expression of Brms1L (Montrer BRMS1L Kits ELISA) depends on beta-catenin (Montrer CTNNB1 Kits ELISA) activity and contributes to follicle stimulating hormone beta (Montrer FSHB Kits ELISA) induction by Gonadotropin-Releasing Hormone.
The Brms1 suppressed pulmonary metastasis and promoted apoptosis of tumor cells located in the lungs but not in the mammary glands.
BRMS1 may participate in transcriptional regulation via interaction with the mSin3.HDAC (Montrer HDAC3 Kits ELISA) complex
results show for the first time that BRMS1 contains both nuclear import and export signals enabling its nucleo-cytoplasmic shuttling
This gene reduces the metastatic potential, but not the tumorogenicity, of human breast cancer and melanoma cell lines. The protein encoded by this gene localizes primarily to the nucleus and is a component of the mSin3a family of histone deacetylase complexes (HDAC). The protein contains two coiled-coil motifs and several imperfect leucine zipper motifs. Alternative splicing results in two transcript variants encoding different isoforms.
breast cancer metastasis suppressor 1
, breast cancer metastasis-suppressor 1
, breast cancer metastasis-suppressor 1 homolog
, breast cancer metastasis-suppressor 1-like protein